ATRC: AtriCure Inc Long-Term Debt Volume

Graphic logo of AtriCure Medical (ATRC)

The historical price chart for AtriCure, Inc. (ATRC) on the GURU.Markets platform illustrates the performance of the company, which develops versatile methods for combating atrial fibrillation. The business relies on the resilience of cardiac surgery to GDP fluctuations and government insurance support, with the indicator standing at 0.07. Patent protection and the lengthy training cycle for physicians provide a competitive advantage, significantly hindering customer switching to other brands.

ATRC AtriCure, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for AtriCure, Inc.

- price and consensus price forecast:
Share Price atricure.com|ATRC - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization AtriCure|ATRC - Enterprise Value
- book capitalization data:
Accounting Value per Share AtriCure|ATRC - Book Capitalization|Market Capitalization to Book Value Ratio atricure.com|ATRC - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity AtriCure, Inc.|ATRC - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital AtriCure Medical|ATRC - Company Aggregate Debts|Debts to Net Assets AtriCure|ATRC - Company Long-Term Debt|Company Short-Term Indebtedness AtriCure
General company analysis:atricure.com (ATRC)
Mass-produced product of AtriCure Medical

For AtriCure, Inc. (ATRC), whose business model is based on the production of sterile medical equipment and adherence to environmental compliance, debt capital often serves as a tool for capacity modernization. By analyzing the company's long-term debt, an investor assesses the total obligations with a maturity of over one year, where a sharp upward trend in the curve may signal a risk of high debt service costs and a decline in share returns.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|STAA (STAAR Surgical Co.) - Company Long-Term Indebtedness|NAGE: Company Long-Term Debt|Long-Term Debt Volume ZimVie Corp (ZIMV)|Company Long-Term Liabilities AngioDynamics, Inc.|Amount of Long-Term Liabilities CERS (cerus.com)|Company Long-Term Debt Teknova|MGRM - Company Long-Term Loans and Borrowings|Sharps Tech - Company Long-Term Liabilities|INFU: Company Long-Term Debts|UTMD (Utah Medical Products) - Company Long-Term Debt|KORU Medical (KRMD) - Company Long-Term Liabilities|Company Long-Term Debts NYXH (Nyxoah)|Long-Term Debt MBOT|Company Long-Term Debt Pro-Dex Corp PDEX|Company Long-Term Indebtedness Zentek Corp ZTEK|Company Long-Term Liabilities Elutia Inc. (ELUT)|milestonescientific.com - Amount of Long-Term Liabilities|Company Long-Term Debt NXGL (NEXGEL)|RVP - Long-Term Debt Volume|HBIO: Company Long-Term Debts|Company Long-Term Debts Femasys Corporation|Meihua Medical Technologies (MHUA) - Company Long-Term Liabilities|Amount of Long-Term Liabilities POAI|Callan JMB Inc (CJMB) - Company Long-Term Debt|Company Long-Term Loans and Borrowings Atrion Corp. (ATRI)|Company Long-Term Debts NURO